                         SEQUENCE LISTING

<110>  CNRS et al
 
<120>  SERCA modulators and their therapeutic uses

<130>  BET20P4422

<160>  7     

<170>  PatentIn version 3.5

<210>  1
<211>  57
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  shRNAs targeting ATP2A2

<400>  1
ccggccagga ttgaagtagc ctcttctcga gaagaggcta cttcaatcct ggttttt          57


<210>  2
<211>  24
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  mlFNbeta forward

<400>  2
ctgcgttcct gctgtgcttc tcca                                              24


<210>  3
<211>  24
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  mlFNbeta reverse

<400>  3
ttctccgtca tctccatagg gatc                                              24


<210>  4
<211>  20
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  mCXCL10 forward

<400>  4
atgacgggcc agtgagaatg                                                   20


<210>  5
<211>  20
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  mCXCL10 reverse

<400>  5
tgaacacgtg ggcaggatag                                                   20


<210>  6
<211>  20
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  mISG15 forward

<400>  6
gtgctccagg acggtcttac                                                   20


<210>  7
<211>  20
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  mISG15 reverse

<400>  7
ctcgctgcag ttctgtacca                                                   20


